M. Kathleen Behrens, Director at Sarepta Therapeutics, Inc. (SRPT), sold 5,000 shares at $85.76 ($429K) on 2021-03-10, disclosed to the SEC on 2021-03-10.
Seasonal sale ($429k) by Director — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |
| IGMS | BUY | 2020-09-14 | $3.2M | — | Filing → |